Elite in Angiosarcoma of the Liver

David Semela

Kantonsspital St. Gallen, 
Sankt Gallen, SG, CH 
Elite in Angiosarcoma of the Liver
Kantonsspital St. Gallen, 
Sankt Gallen, SG, CH 
OverviewLocationsClinical Research

Overview

David Semela practices in Sankt Gallen, Switzerland. Mr. Semela is rated as an Elite expert by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Angiosarcoma of the Liver, Angiosarcoma, Hepatitis C, Hepatitis, and Liver Transplant.

His clinical research consists of co-authoring 89 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Angiosarcoma of the Liver.

Gender
Male

Locations

Kantonsspital St. Gallen, Sankt Gallen, SG, Switzerland
Other Locations
Cantonal Hospital St Gallen, St Gallen, Switzerland
Liestal, BL, Switzerland
St. Gall, Canton, GR, Switzerland
Basel, BS, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
View 1 Less Clinical Trial

89 Total Publications

Surgical Site Infections, Risk Factors, and Outcomes After Liver Transplant.
Surgical Site Infections, Risk Factors, and Outcomes After Liver Transplant.
Journal: JAMA network open
Published: March 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Semela's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile